COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPRNewsWire • 08/20/24
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast ImplantsBusiness Wire • 08/19/24
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 08/06/24
CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical DataPRNewsWire • 06/06/24
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate UpdatePRNewsWire • 05/29/24
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 05/16/24
CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?Zacks Investment Research • 05/10/24
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPRNewsWire • 04/04/24
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 03/26/24
CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, CaliforniaPRNewsWire • 01/08/24
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast ImplantsPRNewsWire • 01/02/24
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 11/09/23
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal FillerPRNewsWire • 11/01/23
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability InitiativePRNewsWire • 09/21/23
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 MillionPRNewsWire • 08/24/23